Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients
NCT01727583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2013-11-08
Summary
This pilot study is aimed at assessing the acute effect of several combinations of lipids differing in their fatty acid composition on glucagon-like-peptide (GLP)-2 and GLP-1 secretion in healthy subjects.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
meal intake
Intake of meals characterized by lipid composition
- DIETARY_SUPPLEMENT
-
Placebo
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Principal Investigators
-
Maurice Beaumont, MD · Nestlé / CDU / Metabolic Unit
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2013-10-31
- Completion
- 2013-11-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
NCT04687514 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
NCT01900340 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
NCT03442972 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study
NCT07141472 ·Status: COMPLETED ·Phase: NA
-
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
NCT00468884 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls
NCT01674972 ·Status: COMPLETED
-
Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
NCT00856700 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Loading During Elective Percutaneous Coronary Intervention
NCT02127996 ·Status: UNKNOWN ·Phase: PHASE2
-
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00876213 ·Status: COMPLETED
-
The Effects of Neprilysin on Glucagon-like Peptide-1
NCT03717688 ·Status: COMPLETED ·Phase: PHASE4
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects
NCT01820806 ·Status: COMPLETED ·Phase: PHASE1
-
To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
NCT03414333 ·Status: COMPLETED ·Phase: NA
-
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
NCT07127354 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
NCT02342834 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
NCT05598008 ·Status: COMPLETED
-
Effects of Gut Peptides on Bone Remodeling
NCT03574064 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
NCT00609154 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effect of GLP-1 on Postprandial Lipid Metabolism
NCT01760772 ·Status: UNKNOWN ·Phase: NA
-
Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
NCT03141632 ·Status: COMPLETED ·Phase: PHASE2
-
Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.
NCT00705952 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
NCT01363609 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA